BEGIN:VCALENDAR PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN VERSION:2.0 BEGIN:VEVENT DESCRIPTION:32nd Pharmacovigilance 2023\n\n26th &\; 27th April 2023\, T he Conference Center at Waltham Woods\, Waltham\, (Boston\, USA)\n\n32nd Pharmacovigilance 2023 event will bring together top pharmaceutical\, bio technology and regulatory representatives under one roof that will addres s the key issues of the industry. Get more from the event\, with a broade r scope bringing the whole communications value chain together.\n\nPlease contact Kavitha at E-mail - kavitha@virtueinsight.co.in  \; \;or call +44 20 3509 3779\n\nDELEGATE REGISTRATION:\n\nSTANDARD PRICE\n\n1 D elegate @ $1699\n\nGroup Discount @ $3398 (3 Delegates for the price of 2 )\n\nSPONSORS:\n\nPharsafer\, Qinecsa Solutions\, EDGYN\, Arisglobal\n\nW e have sponsorship opportunities available for the event\, which gives yo u an opportunity to speak/exhibit\, and create brand awareness. \; He re you can have a dedicated networking time\, meet the leading internatio nal vendors and expand your knowledge of the latest business models. Plea se email to kavitha@virtueinsight.co.in  \; \;for more details.\n \nKEY SPEAKERS:\n\n\nKHAUDEJA BANO\, Vice President\, Combination Product Quality\, Amgen\nBRUNO MENDEZ\, VP Global Quality Head Pharmacovigilance \, Sanofi\nMARIETTE BOERSTOEL-STREEFLAND\, SVP Patient Safety\, Chief Saf ety Officer\, Alexion Pharmaceuticals\nJEREMY JOKINEN\, VP Global Risk Ma nagement &\; International Patient Safety\, Bristol-Myers Squibb\nCARM IT STRAUSS\, Executive Director\, Head of Risk Management and Organ Toxic ity\, Takeda Pharmaceuticals\nSHARON REID\, Director\, Risk Management Pr oduct Lead\, Pfizer\nRENA PANDIT\, Executive Director\, Global Patient Sa fety Head of PV Compliance &\; Training\, Amgen\nAYSE BAKER\, Vice Pre sident of Regulatory Affairs\, Almatica (Alvogen)\nHUMAIRA QURESHI\, Pres ident\, Qinecsa Solutions\nMARITESS ESGUERRA\, Senior PV Process Director \, Genentech\nJAYLAXMI NALAWADE\, Associate Director - Pharmacovigilance and REMS\, Lupin\nDEEPA VENKATARAMAN\, Vice President\, Head of Drug Safe ty and PV\, Corcept Therapeutics\nKANAN BHAVSAR\, Medical Director\, Pha rmacovigilance\, Deciphera Pharmaceuticals\nSHEETAL KHEDKAR\, Deputy Ther apeutic Area Safety Head\, ED\, Johnson &\; Johnson\nGRAEME LADDS\, CE O\, PharSafer\nMARCIN VON GROTTHUSS\, Principal Scientist\, Investigative Toxicology\, Takeda Pharmaceuticals\nKAL ELHOREGY\, Director\, Risk Eval uation &\; Mitigation Strategy (REMS) Programs\, Amneal Pharmaceutical s\nNANCY DUBOIS\, Head of Global Patient Safety US\, Merck-EMD Serono\nNI SHITH JOBANPUTRA\, Disease Area Cluster Lead\, Worldwide Safety\, Pfizer\ nCAMILLE DISS\, CPO\, EDGYN\nBEN LOCWIN\, Executive SME\, Black Diamond N etworks\nADEL ABOU-ALI\, Head of Benefit Risk Center of Excellence (CoE)\ , GPSE\, Takeda\nBILL HADDOCK\, VP Pharmacovigilance &\; GXP Quality\, Ovid Therapeutics\nAJINKYA INAMDAR\, Senior Director (Global Medical Saf ety Strategy)\, BioNTech SE\nTEODORA DOHERTY\, Global Medical Safety (GMS )\, Medical Safety Officer\, Janssen Research &\; Development\nLINA OG BU\, Medical Director Drug Safety &\; Pharmacovigilance\, Arcus biosci ences\nSTEPHEN F. AMATO\, Director\, Global Regulatory Affairs &\; Qua lity Assurance Programs\, Northeastern University\nJERRY K. KOUNGA\, Inve stigational Drug Lead Clinical Research Pharmacist\, Ascension Wisconsin Research Institute\nKAPIL BHUTADA\, Director\, Pharmacovigilance Complian ce &\; Training\, Medicago\nELIZABETH BAKER\, Associate Professor\, Vi rginia Commonwealth University\nBENJAMIN BROWN\, Executive Director\, Ame rican Society of Pharmacovigilance\nJESSICA VAUGHN\, Attorney at Law\, Wi ley Rein\n\nPlus more joining soon\n\nFOCUSES ON\n\n\nPharmacovigilance: What comes next for the PV industry?\nChallenges and opportunities for be tter future of Pharmacovigilance\nOutsourcing - Best Practices\, Challeng es &\; key consideration in choosing right vendor\nProper communicatio n between - Sponsor – Site – CRO – Patients\nQuality\, Safety &\; Sign al Detection – Best practice\nModern Technologies in Pharmacovigilance - The Way Forward\nAutomation in Pharmacovigilance: A Closer look at use ca ses\nPrioritising patients – Ensuring patient safety first\nNext generati on pharmacovigilance for enhanced patient safety\nPV operations within fi nancial and logistical constraints\nRisk Management – Proper plans for a perfect tomorrow\nWhy does pharmacovigilance sometimes fail and where cou ld the fault lie?\nManaging Pharmacovigilance Audits &\; Inspections\n The developing regulatory framework in advanced and developing markets\nB oldly shaping the future\nBest practices and lessons learnt from the pand emic\nBe part of a major networking opportunity\n\nWHO SHOULD ATTEND\n\nC EO’s\, CTO’s\, CIO’s\, Presidents\, VPs\, Directors\, Heads\, Managers\, Scientific Advisors\, Consultants of:\n\nPharmacovigilance\, Pharmacoepid emiology\, Pharmacogenomics\, Drug/Product Safety\, Drug Development\, In formation and Clinical Data Management\, Clinical Pharmacology\, Clinical Safety\, Periodical safety update Reports\, Risk Management\, Research & amp\; Development\, Quality Assurance\, Patient Safety\, Signal Detection \, Safety Surveillance\, Outcomes Research\, Data Analysis\, Epidemiology \, Medical Affairs\, Regulatory Affairs and Compliance\, Information tech nology\, Sales and Marketing\n\nEnjoy and make the best out of our dedica ted networking time\, meet the leading international vendors showcasing t he products of tomorrow in the co-located exhibition. Expand your knowled ge of the latest business models and strategies in the high-level confere nce.\n DTEND:20230427T170000 DTSTAMP:20260512T214259Z DTSTART:20230426T090000 LOCATION:Conference Center at Waltham Woods\, 860\, Winter Street\, Middle sex County\, 02451\, SEQUENCE:0 SUMMARY:32nd Pharmacovigilance 2023\n26th &\; 27th April 2023\, The Con ference Center at Waltham Woods\, Waltham\, (Boston\, USA)\n32nd Pharmaco vigilance 202... UID:4e2625d2-267c-4f4e-9fe2-ff3b8a5e0851 END:VEVENT END:VCALENDAR